Arrowhead Pharmaceuticals, Inc. company logo
Arrowhead Pharmaceuticals, Inc. logo

ARWR EBITDA

Annual EBITDA

-$680.55M$802.82M-656.58%

Summary

Current Value
As of today, ARWR annual EBITDA is -$680.55M, down -656.58% on
Historical Performance
ARWR annual EBITDA is down -253.52% over the past 3 years, down -383.45% over the past 5 years
All-Time High Comparison
ARWR annual EBITDA is currently -656.58% below its historical high of $122.27M set on
3-Year Low Comparison
ARWR annual EBITDA is at its 3-year low
Sector Comparison
ARWR annual EBITDA is higher than 0.88% of companies in Healthcare sector

EBITDA Chart

SUGGESTED SERIES

Performance

ARWR Performance
MetricDateValue1Y3Y5Y15Y
Annual EBITDA-$680.55M-656.6%-253.5%-383.4%-7017.0%
Quarterly EBITDA-$429.42M-950.5%-311.0%-588.4%-10000.0%
TTM EBITDA-$680.55M-656.6%-253.5%-383.3%-9365.6%
Price$43.65+12.0%+55.6%-38.6%+689.3%
PE Ratio-––––
Annual Revenue$450.82M-45.6%+87.3%+226.0%+10000.0%
Annual EPS-$5.11-10000.0%-165.9%-276.6%-468.1%
-$707.17M-819.1%-245.0%-374.5%-7093.8%
Annual Net Income-$717.13M-2481.4%-242.7%-409.1%-8063.2%

EBITDA Highs

ARWR Annual EBITDA Highs Comparison
PeriodHighDateCurrent
3Y$122.27M-656.6%
5Y$122.27M-656.6%
All$122.27M-656.6%

EBITDA Lows

ARWR Annual EBITDA Lows Comparison
PeriodLowDateCurrent
3Y-$680.55Mat low
5Y-$680.55Mat low
All-$680.55Mat low

EBITDA History

YearValueChange
-$680.55M-656.6%
$122.27M+121.0%
-$582.49M-202.6%
-$192.51M-14.5%
-$168.09M-19.4%
-$140.77M-61.4%
-$87.22M-232.9%
$65.63M+228.1%
-$51.24M-58.6%
-$32.31M+60.7%
-$82.29M-0.8%
-$81.60M-72.5%
-$47.30M-135.2%
-$20.11M-4.0%
-$19.34M-102.3%
YearValueChange
-$9.56M-17.4%
-$8.15M+50.4%
-$16.44M+46.3%
-$30.59M-11.9%
-$27.35M-39.6%
-$19.60M-124.8%
-$8.72M-223.6%
-$2.69M-2,754.0%
-$94.40K+28.8%
-$132.50K-29.0%
-$102.70K-1.1%
-$101.60K-111.2%
-$48.10K-100.4%
-$24.00K+56.2%
-$54.80K-

FAQ

What is the current annual EBITDA of ARWR?
As of today, ARWR annual EBITDA is -$680.55M
What is 1-year change in ARWR annual EBITDA?
ARWR annual EBITDA is down -656.58% year-over-year
What is 3-year change in ARWR annual EBITDA?
ARWR annual EBITDA is down -253.52% over the past 3 years
How far is ARWR annual EBITDA from its all-time high?
ARWR annual EBITDA is currently -656.58% below its historical high of $122.27M set on September 30, 2025
How does ARWR annual EBITDA rank versus sector peers?
ARWR annual EBITDA is higher than 0.88% of companies in Healthcare sector
When is ARWR next annual earnings release?
As of today, the next annual earnings release for ARWR has not been scheduled

EBITDA Formula

EBITDA = Net Income + + +

Data Sources & References

  1. ARWR Official Website arrowheadpharma.com
  2. ARWR Profile on Yahoo Finance finance.yahoo.com/quote/ARWR
  3. ARWR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/arwr